Fady I. Malik
Guy's Hospital(GB)Oregon Health & Science University(US)Highland Community College - Illinois(US)Cytokinetics (United States)(US)
Publications by Year
Research Areas
Cardiomyopathy and Myosin Studies, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies, Heart Failure Treatment and Management, Cardiovascular Effects of Exercise
Most-Cited Works
- → Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure(2020)627 cited
- → Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure(2011)591 cited
- → The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial(2011)329 cited
- → Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial(2016)287 cited
- → Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study(2011)260 cited
- → Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy(2024)246 cited